Suppr超能文献

脾切除术通过诱导免疫耐受来延长心脏移植的存活时间。

Splenectomy increases the survival time of heart allograft via developing immune tolerance.

作者信息

Zhu Jinguo, Chen Shuzhen, Wang Jinju, Zhang Cheng, Zhang Wei, Liu Peng, Ma Ruilian, Chen Yanfang, Yao Zhen

出版信息

J Cardiothorac Surg. 2013 May 16;8:129. doi: 10.1186/1749-8090-8-129.

Abstract

BACKGROUND

The spleen is an active lymphoid organ. The effect of splenectomy on the immune response remains unclear. This study investigated whether splenectomy can induce immune tolerance and has a beneficial role in cardiac allograft.

METHODS

Wistar rats were used for heart donors. The Sprague-Dawley (SD) rats designated as the recipients of heart transplantation (HT) were randomly assigned into four groups: sham, splenectomy, HT, splenectomy + HT. The survival of transplanted hearts was assessed by daily checking of abdominal palpation. At various time points after transplantation, the transplanted hearts were collected and histologically examined; the level of CD4+CD25+ T regulatory lymphocytes (Tregs) and rate of lymphocyte apoptosis (annexin-v+ PI+ cells) in the blood were analyzed by using flow cytometric method.

RESULTS

  1. Splenectomy significantly prolonged the mean survival time of heart allografts (7 ± 1.1 days and 27 ± 1.5 days for HT and splenectomy + HT, respectively; n = 12-14/group, HT vs. splenectomy + HT, p < 0.001); 2) Splenectomy delayed pathological changes (inflammatory cell infiltration, myocardial damage) of the transplanted hearts in splenectomy + HT rats; 3) The level of CD4+CD25+ Tregs in the blood of splenectomized rats was significantly increased within 7 days (2.4 ± 0.5%, 4.9 ± 1.3% and 5.3 ± 1.0% for sham, splenectomy and splenectomy + HT, respectively; n = 15/group, sham vs. splenectomy or splenectomy + HT, p < 0.05) after splenectomy surgery and gradually decreased to baseline level; 4) Splenectomy increased the rate of lymphocyte apoptosis (day 7: 0.3 ± 0.05%, 3.9 ± 0.9% and 4.1 ± 0.9% for sham, splenectomy and splenectomy + HT, respectively; n = 15/group, sham vs. splenectomy or splenectomy + HT, p < 0.05) in a pattern similar to the change of the CD4+CD25+ Tregs in the blood.

CONCLUSIONS

Splenectomy inhibits the development of pathology and prolongs the survival time of cardiac allograft. The responsible mechanism is associated with induction of immune tolerance via elevating CD4+CD25+ Tregs and increasing lymphocyte apoptosis.

摘要

背景

脾脏是一个活跃的淋巴器官。脾切除术对免疫反应的影响尚不清楚。本研究调查了脾切除术是否能诱导免疫耐受并对心脏同种异体移植发挥有益作用。

方法

选用Wistar大鼠作为心脏供体。将指定为心脏移植(HT)受体的Sprague-Dawley(SD)大鼠随机分为四组:假手术组、脾切除组、心脏移植组、脾切除+心脏移植组。通过每日腹部触诊评估移植心脏的存活情况。在移植后的不同时间点,收集移植心脏并进行组织学检查;采用流式细胞术分析血液中CD4+CD25+调节性T淋巴细胞(Tregs)水平和淋巴细胞凋亡率(膜联蛋白-v+PI+细胞)。

结果

1)脾切除术显著延长了心脏同种异体移植的平均存活时间(心脏移植组和脾切除+心脏移植组分别为7±1.1天和27±1.5天;每组n = 12 - 14只,心脏移植组与脾切除+心脏移植组比较,p < 0.001);2)脾切除术延缓了脾切除+心脏移植组大鼠移植心脏的病理变化(炎症细胞浸润、心肌损伤);3)脾切除术后7天内,脾切除大鼠血液中CD4+CD25+ Tregs水平显著升高(假手术组、脾切除组和脾切除+心脏移植组分别为2.4±0.5%、4.9±1.3%和5.3±1.0%;每组n = 15只,假手术组与脾切除组或脾切除+心脏移植组比较,p < 0.05),并逐渐降至基线水平;4)脾切除术增加了淋巴细胞凋亡率(第7天:假手术组、脾切除组和脾切除+心脏移植组分别为0.3±0.05%、3.9±0.9%和4.1±0.9%;每组n = 15只,假手术组与脾切除组或脾切除+心脏移植组比较,p < 0.05),其变化模式与血液中CD4+CD25+ Tregs的变化相似。

结论

脾切除术可抑制病理发展并延长心脏同种异体移植的存活时间。其相关机制与通过升高CD4+CD25+ Tregs诱导免疫耐受和增加淋巴细胞凋亡有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7461/3667018/be0077bd48f8/1749-8090-8-129-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验